{"id":43491,"date":"2025-10-15T22:04:12","date_gmt":"2025-10-15T14:04:12","guid":{"rendered":"https:\/\/flcube.com\/?p=43491"},"modified":"2025-10-15T22:04:13","modified_gmt":"2025-10-15T14:04:13","slug":"jingze-bio-and-cms-subsidiary-partner-to-commercialize-key-products-in-reproduction-and-ophthalmology","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=43491","title":{"rendered":"Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">On September 12, 2025, Jingze Biopharmaceutical (Hefei) Co., Ltd., based in China, and a subsidiary of China Medical System Holdings (CMS, <a href=\"https:\/\/www.google.com\/finance\/quote\/0867:HKG\">HKG: 0867<\/a>; <a href=\"https:\/\/www.google.com\/finance\/quote\/8A8:SGX\">SGX: 8A8<\/a>), announced a strategic cooperation agreement. The collaboration centers on the commercialization of multiple core products in the fields of assisted reproduction and ophthalmology, with the goal of expanding into domestic and international markets.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Core Products and Market Potential<\/strong><br>The partnership will focus on three key products from Jingze Bio: JZB30 and JZB33 for assisted reproduction, and JZB05 for ophthalmology. These products address significant unmet clinical needs and specialized treatment segments, offering substantial market potential.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>International Expansion<\/strong><br>Beyond the domestic market, Jingze Bio has signed a License and Supply Agreement with Rxilient Medical Pte. Ltd., a subsidiary of CMS, granting Rxilient the rights to JZB30, JZB33, and JZB05 in regions including Southeast Asia, Australia, New Zealand, South Korea, the Middle East, and Africa.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Regulatory Preparation<\/strong><br>Both parties have initiated preparations for the JZB30 project&#8217;s application materials for the Singapore market.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>On September 12, 2025, Jingze Biopharmaceutical (Hefei) Co., Ltd., based in China, and a subsidiary&#8230;<\/p>\n","protected":false},"author":1,"featured_media":43496,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10],"tags":[325,844,4387,44,4256],"class_list":["post-43491","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-china-medical-system","tag-hkg-0867","tag-jingze-biopharmaceutical","tag-ophthalmology","tag-sgx-8a8"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"On September 12, 2025, Jingze Biopharmaceutical (Hefei) Co., Ltd., based in China, and a subsidiary of China Medical System Holdings (CMS, HKG: 0867; SGX: 8A8), announced a strategic cooperation agreement. The collaboration centers on the commercialization of multiple core products in the fields of assisted reproduction and ophthalmology, with the goal of expanding into domestic and international markets.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=43491\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology\" \/>\n<meta property=\"og:description\" content=\"On September 12, 2025, Jingze Biopharmaceutical (Hefei) Co., Ltd., based in China, and a subsidiary of China Medical System Holdings (CMS, HKG: 0867; SGX: 8A8), announced a strategic cooperation agreement. The collaboration centers on the commercialization of multiple core products in the fields of assisted reproduction and ophthalmology, with the goal of expanding into domestic and international markets.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=43491\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-15T14:04:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-15T14:04:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1502-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43491#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43491\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology\",\"datePublished\":\"2025-10-15T14:04:12+00:00\",\"dateModified\":\"2025-10-15T14:04:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43491\"},\"wordCount\":180,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43491#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1502-1.webp\",\"keywords\":[\"China Medical System\",\"HKG: 0867\",\"Jingze Biopharmaceutical\",\"Ophthalmology\",\"SGX: 8A8\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43491#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43491\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=43491\",\"name\":\"Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43491#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43491#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1502-1.webp\",\"datePublished\":\"2025-10-15T14:04:12+00:00\",\"dateModified\":\"2025-10-15T14:04:13+00:00\",\"description\":\"On September 12, 2025, Jingze Biopharmaceutical (Hefei) Co., Ltd., based in China, and a subsidiary of China Medical System Holdings (CMS, HKG: 0867; SGX: 8A8), announced a strategic cooperation agreement. The collaboration centers on the commercialization of multiple core products in the fields of assisted reproduction and ophthalmology, with the goal of expanding into domestic and international markets.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43491#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43491\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43491#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1502-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1502-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43491#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology - Insight, China&#039;s Pharmaceutical Industry","description":"On September 12, 2025, Jingze Biopharmaceutical (Hefei) Co., Ltd., based in China, and a subsidiary of China Medical System Holdings (CMS, HKG: 0867; SGX: 8A8), announced a strategic cooperation agreement. The collaboration centers on the commercialization of multiple core products in the fields of assisted reproduction and ophthalmology, with the goal of expanding into domestic and international markets.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=43491","og_locale":"en_US","og_type":"article","og_title":"Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology","og_description":"On September 12, 2025, Jingze Biopharmaceutical (Hefei) Co., Ltd., based in China, and a subsidiary of China Medical System Holdings (CMS, HKG: 0867; SGX: 8A8), announced a strategic cooperation agreement. The collaboration centers on the commercialization of multiple core products in the fields of assisted reproduction and ophthalmology, with the goal of expanding into domestic and international markets.","og_url":"https:\/\/flcube.com\/?p=43491","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-15T14:04:12+00:00","article_modified_time":"2025-10-15T14:04:13+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1502-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=43491#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=43491"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology","datePublished":"2025-10-15T14:04:12+00:00","dateModified":"2025-10-15T14:04:13+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=43491"},"wordCount":180,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=43491#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1502-1.webp","keywords":["China Medical System","HKG: 0867","Jingze Biopharmaceutical","Ophthalmology","SGX: 8A8"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=43491#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=43491","url":"https:\/\/flcube.com\/?p=43491","name":"Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=43491#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=43491#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1502-1.webp","datePublished":"2025-10-15T14:04:12+00:00","dateModified":"2025-10-15T14:04:13+00:00","description":"On September 12, 2025, Jingze Biopharmaceutical (Hefei) Co., Ltd., based in China, and a subsidiary of China Medical System Holdings (CMS, HKG: 0867; SGX: 8A8), announced a strategic cooperation agreement. The collaboration centers on the commercialization of multiple core products in the fields of assisted reproduction and ophthalmology, with the goal of expanding into domestic and international markets.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=43491#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=43491"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=43491#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1502-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1502-1.webp","width":1080,"height":608,"caption":"Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=43491#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1502-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=43491"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43491\/revisions"}],"predecessor-version":[{"id":43497,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43491\/revisions\/43497"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/43496"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=43491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=43491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=43491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}